SHSE:688393 (China)
Â
Class A
Â¥
20.18
(+1.1%)
Nov 29
Business Description
Guangzhou LBP Medicine Science & Technology Co Ltd
ISIN : CNE1000043R4
Share Class Description:
SHSE:688393: Class ACompare
Compare
Traded in other countries / regions
688393.China IPO Date
2020-08-20Description
Guangzhou LBP Medicine Science & Technology Co Ltd is engaged in production and sales of in vitro diagnostic reagents and instruments. The company's products include Fluorescence in situ hybridization (FISH) series; Immunohistochemistry (IHC) series; Liquid - based cytology (LBP) series; PCR series; and medical laboratory.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.61 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.76 | |||||
| Interest Coverage | 27.79 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 10.32 | |||||
| Beneish M-Score | -2.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.6 | |||||
| 3-Year EBITDA Growth Rate | -23.4 | |||||
| 3-Year EPS without NRI Growth Rate | -25.9 | |||||
| 3-Year Book Growth Rate | 2.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.17 | |||||
| 9-Day RSI | 56.71 | |||||
| 14-Day RSI | 57.41 | |||||
| 6-1 Month Momentum % | 9.24 | |||||
| 12-1 Month Momentum % | -30.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.92 | |||||
| Quick Ratio | 7.74 | |||||
| Cash Ratio | 1.49 | |||||
| Days Inventory | 187.45 | |||||
| Days Sales Outstanding | 179.82 | |||||
| Days Payable | 82.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.74 | |||||
| Dividend Payout Ratio | 0.4 | |||||
| Forward Dividend Yield % | 0.74 | |||||
| 5-Year Yield-on-Cost % | 0.74 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 1.05 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.91 | |||||
| Operating Margin % | 3.3 | |||||
| Net Margin % | 6.48 | |||||
| FCF Margin % | -1.68 | |||||
| ROE % | 2.53 | |||||
| ROA % | 2.33 | |||||
| ROIC % | 2.12 | |||||
| ROC (Joel Greenblatt) % | 2.42 | |||||
| ROCE % | 1.31 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 63.06 | |||||
| PE Ratio without NRI | 53.96 | |||||
| Shiller PE Ratio | 26.83 | |||||
| PS Ratio | 4.04 | |||||
| PB Ratio | 1.48 | |||||
| Price-to-Tangible-Book | 1.55 | |||||
| Price-to-Operating-Cash-Flow | 111.49 | |||||
| EV-to-EBIT | 105.94 | |||||
| EV-to-EBITDA | 105.94 | |||||
| EV-to-Revenue | 3.61 | |||||
| EV-to-FCF | -215.02 | |||||
| Price-to-Projected-FCF | 2.24 | |||||
| Price-to-Graham-Number | 1.93 | |||||
| Price-to-Net-Current-Asset-Value | 3.37 | |||||
| Price-to-Net-Cash | 224.22 | |||||
| Earnings Yield (Greenblatt) % | 0.94 | |||||
| FCF Yield % | -0.44 | |||||
| Forward Rate of Return (Yacktman) % | -44.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guangzhou LBP Medicine Science & Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 495.462 | ||
| EPS (TTM) (Â¥) | 0.32 | ||
| Beta | 0.97 | ||
| Volatility % | 41.34 | ||
| 14-Day RSI | 57.41 | ||
| 14-Day ATR (Â¥) | 1.150865 | ||
| 20-Day SMA (Â¥) | 19.559 | ||
| 12-1 Month Momentum % | -30.9 | ||
| 52-Week Range (Â¥) | 12.83 - 26.94 | ||
| Shares Outstanding (Mil) | 93.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guangzhou LBP Medicine Science & Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guangzhou LBP Medicine Science & Technology Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guangzhou LBP Medicine Science & Technology Co Ltd Frequently Asked Questions
What is Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393)'s stock price today?
The current price of SHSE:688393 is ¥20.18. The 52 week high of SHSE:688393 is ¥26.94 and 52 week low is ¥12.83.
When is next earnings date of Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393)?
The next earnings date of Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393) is .
Does Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393) pay dividends? If so, how much?
The Dividend Yield %  of Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393) is 0.74% (As of Today), Highest Dividend Payout Ratio of Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393) was 0.63. The lowest was 0.38. And the median was 0.42. The  Forward Dividend Yield % of Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393) is 0.74%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers